1- Kalman B, Toldy E. Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis. Neuromolecular Med 2014 Jun;16(2):265-79.
2- Librau RS, Singer SM, McDevitt HO. Th1 and Th2 CD41 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34–48.
3- Hasheminia SJ, Tolouei S, Zarkesh-Esfahani SH, Shaygannejad V, Shirzad HA, Torabi R, Hashem Zadeh Chaloshtory M. Cytokines gene expression in newly diagnosed multiple sclerosis patients. Iran J Allergy Asthma Immunol 2015 Apr;14(2):208-16.
4- Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, Pelidou SH, Kyritsis AP, Fotopoulos A. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 2011 May 5;10:3.
5- Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 2005;252(5):v3–9.
6- Herrero-Herranz E, Pardo LA, Gold R, Linker RA. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 2008;30:162–73.
7- García-Martín E, Agúndez JA, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, Díaz-Sánchez M, Pisa D, Turpín-Fenoll L, Alonso-Navarro H, Ayuso-Peralta L, Torrecillas D, Plaza-Nieto JF, Jiménez-Jiménez FJ. Vitamin D3 receptor (VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One 2013 Jun 20;8(6):e65487.
8- Huang J, Xie Z. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case–control studies, Journal of the Neurological Sciences 2012;313:79–85.
9- Goldenberg MM. Multiple sclerosis review. P & T 2012;37(3): 175–84.
10- Kurland LT. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Amer. J. Hygiene 1952;55: 457–76.
11- Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl 2008;188: 34–40.
12- Ebers GC, Kukay K, Bulmann DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13: 472–6.
13- Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat Genet 1996;13:464–8.
14- Fukazawaa T, Yabeb I, Kikuchib S, Sasakib H, Hamadaa T, Miyasaka K, Tashiro K. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. Journal of the Neurological Sciences 1999;166: 47–52.
15- Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA,et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA–DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5:e1000369.
16- Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheumatic Disease Clinics of North America 2012;38(1): 125–39.
17- Jurutka PW, Bartik L, Whitfield GK, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. Journal of Bone and Mineral Research 2007;22(2): v2-10.
18- Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991;87: 1103–7.
19- Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93: 7861–4.
20- Meehan TF, DeLuca HF. The vitamin D receptor is necessary for 1𝛼,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice. Archives of Biochemistry and Biophysics 2002; 408(2): 200–4.
21- Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A. Positive Association of Vitamin D Receptor Gene Variations with Multiple Sclerosis in South East Iranian Population. Hindawi Publishing Corporation BioMed Research International, Vol. 2015, Article ID 427519, 4 pages.
22- Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci. 2011 Jun 15;305(1-2): 116-20.
23- Simon K, Munger K, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis 2010; 16(2):133–8.
24- Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143–56.
25- Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. Journal of the Neurological Sciences 2000;177(1): 65–71.
26- Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2005; 19(1): 25–38.
27- Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler. 2012 Jan;18(1): 16-22.
28- McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
29- Nasiri H, Forouzandeh M, Rasaee MJ and Rahbarizadeh F. Modified salting-out method: High-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005; 19(6): 229-32.
30- Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert J, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmunity Reviews 2009;8: 621–6.
31- Smolders J, Damoisaux J, Menheere P, Cohen Tervaert JW, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunology 2009;207: 117–21.
32- Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, et al. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler 2008;14:1280–3.
33- Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL, et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 2004;62:2323–5.
34- Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler 2009;15:563–70.